Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 12, 2023 02:00 ET | Source: Salipro Biotech AB

Salipro Biotech enters into research collaboration with Sumitomo Pharma to advance a drug discovery program

The collaboration leverages Salipro Biotech’s unique expertise and its Salipro® platform technology to stabilize a challenging drug target to investigate the pharmacological characteristics of a...
August 07, 2023 06:43 ET | Source: Research and Markets

Over 1000 Orphan Drugs in Clinical Trials in the US - Eylea, Actimmune, Ravicti Among Key Approved Therapies

Dublin, Aug. 07, 2023 (GLOBE NEWSWIRE) -- The "US Orphan Drugs Market, Drugs Sales, Price, Dosage & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's offering. ...
April 26, 2023 08:00 ET | Source: QSAM Biosciences Inc.

QSAM Biosciences Receives Second Key Patent in Europe for its Clinical Stage Radiopharmaceutical Drug Candidate, CycloSam®

Austin, TX, April 26, 2023 (GLOBE NEWSWIRE) -- QSAM Biosciences Inc. (OTCQB: QSAM), a company developing next-generation therapeutic radiopharmaceuticals, including Samarium-153-DOTMP (CycloSam®),...
February 28, 2023 10:24 ET | Source: Vantage Market Research

Global Compound Management Market Size To Reach $897.1 Billion at a CAGR of 16.5% | Vantage Market Research

WASHINGTON, Feb. 28, 2023 (GLOBE NEWSWIRE) -- The Global Compound Management Market is valued at USD 355.5 Billion in 2021 and is projected to reach a value of USD 897.1 Billion by 2028 at a CAGR...
January 31, 2023 10:38 ET | Source: Research and Markets

Outlook on the Monkeypox Treatment Global Market to 2035 - Focus on Therapeutics, Vaccines and Diagnostic Kits

Dublin, Jan. 31, 2023 (GLOBE NEWSWIRE) -- The "Monkeypox Treatment Market: Focus on Therapeutics, Vaccines and Diagnostic Kits: Distribution by Type of Product, Drug Developers, Drug Candidates,...
January 04, 2023 06:48 ET | Source: Research and Markets

Opportunities in the Artificial Intelligence in Drug Discovery Market Investor Report: Savings of $8.57 Billion Enabled by AI

Dublin, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The "Investor Series: Opportunities in the Artificial Intelligence in Drug Discovery Market" report has been added to ResearchAndMarkets.com's offering. ...
December 16, 2022 07:23 ET | Source: Research and Markets

Global SARM1 Inhibitors Market Report 2022 to 2040 - by Target Indications, Type of Molecules, Drug Developers, Drug Candidates and Key Geographies

Dublin, Dec. 16, 2022 (GLOBE NEWSWIRE) -- The "SARM1 Inhibitors Market by Target Indications, Type of Molecules, Drug Developers, Drug Candidates and Key Geographies: Industry Trends and Global...
December 15, 2022 05:18 ET | Source: Research and Markets

Immune Checkpoint Inhibitors Clinical Trial Analysis 2022: Wide Variety of Clinical and Preclinical Research Currently Ongoing Bodes Well for Growth

Dublin, Dec. 15, 2022 (GLOBE NEWSWIRE) -- The "Immune Checkpoint Inhibitors: Analysis of Clinical Trial Results (Featuring Recently Published Trial Results, Contemporary Pipeline Review, Clinical...
August 15, 2022 04:38 ET | Source: Research and Markets

Artificial Intelligence In Drug Discovery Global Market Report 2022: Featuring Key Players IBM, Microsoft, Cloud Pharmaceuticals & Others

Dublin, Aug. 15, 2022 (GLOBE NEWSWIRE) -- The "Artificial Intelligence (AI) In Drug Discovery Global Market Report 2022, By Technology, By Drug Type, By Therapeutic Type, By End-Users" report has...
July 18, 2022 05:48 ET | Source: Research and Markets

Global Compound Management Market (2022 to 2030) - Rising Demand for Outsourcing Compound Management Services is Driving Growth

Dublin, July 18, 2022 (GLOBE NEWSWIRE) -- The "Global Compound Management Market Size, Share & Trends Analysis Report by Type (Products, Service), by Sample Type (Chemical Compounds, Bio...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right